BALI, Indonesia, May 20, 2025 /PRNewswire/ -- Maya Sanur Resort & Spa is thrilled to introduce Rue, a vibrant new all-day dining venue that combines the casual charm of a street-side café with contemporary style and modern comfort. Opening its doors to the public on 19th of April 2025, Rue offers a fresh vibe to Sanur's dining scene—inviting locals, resort guests, tourists, and digital nomads to enjoy the flavorful dishes in a relaxed setting, breaks away from the formality of hotel dining. Open daily from 7 AM to 10 PM, the restaurant welcomes guests throughout the day—from a leisurely morning coffee and hearty brunch to a relaxed lunch or a lively dinner with crafted cocktails.
Led by Chef Justin Mauté, Culinary, Food & Beverage Director of Maya Resorts, Rue's menu reflects his creative flair by bringing the essence of Canggu-inspired café into the heart of Sanur through his culinary creations. The menu blends the fresh flavor of Australian café-style favorites with a touch of European flair, offering bold international tastes with a modern twist. Guests can indulge in signature dishes such as The Big Rue Burger, Rue Fried Chicken Bucket, Roast Fire Camembert and tantalizing handcrafted Pizzas freshly baked in a Lava Stone oven—delivering professional-quality pizza crusts. To sweeten the experience, Rue also features tempting assorted cakes and pastries display featuring Valrhona Caramelia, Burnt Cheesecake, Choco Suisse Danish and more. A dedicated Kids Corner makes Rue even more inviting for families, allowing little ones to play while parents can relax with good food and coffee.
To celebrate its opening, Rue offers exciting promotions including the first ten dine-in customers will receive 50% off for their breakfast. Every Tuesday and Sunday, from 5 PM to 10 PM, enjoy "2 for 1" pizza offer, where every second pizza is complimentary. Daily Happy Hour from 5 PM to 7 PM features 50% off for selected cocktails and wines by the glass, along with other special promotions throughout the week.
With warm service, a diverse menu and stylish interior, Rue is set to become the newest go-to spot for all-day dining in Sanur. Whether it's for a cozy morning coffee, a satisfying brunch, or lively dinner, Rue offers the ideal space to gather, enjoy good food and good times.
Rue
Jl. Danau Tamblingan No. 89M, Sanur
Denpasar, Bali
WhatsApp +62 812 2701 6916
Email fb-admin@mayasanur.com
ABOUT RUE
Rue is a modern all-day dining venue located at Maya Sanur Resort & Spa. Built as a vibrant street-side destination for brunch lovers, coffee drinkers, food explorers, and laid-back socializers, Rue delivers a globally inspired menu that draws from global influences featuring the fresh flavor of Australian café-style favorites with a touch of European flair, offering bold international tastes with a modern twist in a chic yet approachable setting. Rue is where locals and travelers meet for good food and good vibes every day of the week.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Rue Launches in Bali's Favorite Beach Town: A Chic Street-Side Dining Experience in the Heart of Sanur
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
